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Cinnamon bark is used worldwide due to its characteristic fl avour and medicinal properties. Ceylon cinnamon or 
“true” cinnamon bark refers to the dried inner bark of the shoots of Cinnamomum verum J. Presl, originated from Sri 
Lanka. The bark of some other species of this genus, Cinnamomum cassia Blume (Chinese cinnamon), C. burmanni 
(Nees & T. Nees) Blume (Indonesian cinnamon), and C. loureiroi Nees (Saigon cinnamon) are also marketed and 
sold as cinnamon. They are characterised by a signifi cantly higher amount of coumarin compared to Ceylon 
cinnamon bark. Since coumarin may be potentially hepatotoxic, the aim of this study was to determine coumarin 
level in commercial samples of cinnamon bark and in cinnamon-containing dietary supplements present on the 
Serbian market. HPLC analysis showed lowest coumarin content in Ceylon cinnamon bark samples (0.08–0.15 
mg g–1), whereas other samples contained a signifi cantly higher amounts of coumarin (1.38–5.80 mg g–1). Cinnamon 
based dietary supplements contained 0.007–1.19 mg coumarin/tablet. The obtained results indicate that the majority 
of commercial samples of cinnamon bark on the Serbian market do not originate from the Ceylon cinnamon but from 
other species of this genus, and that consumed amount of certain products should be taken into account since the 
tolerable daily intake of coumarin is limited.
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Cinnamon bark, also known as cinnamon, is well-known since antiquity due to its 
characteristic fl avour and medicinal properties. It is used as a spice as well as in phytotherapy 
for symptomatic treatment of mild diarrhoea and mild spasmodic gastrointestinal complaints 
including bloating and fl atulence (T  et al., 2006; EMA, 2011). Cinnamon bark and 
its essential oil are applied as fl avouring agents in the food, beverage, and pharmaceutical 
industries (A  et al., 2015).
Diff erent species of the genus Cinnamon are commonly referred to as ‘cinnamon’. 
Ceylon cinnamon or “true” cinnamon refers to the dried inner bark of the shoots of 
Cinnamomum verum J. Presl (syn. C. zeylanicum Blume) (Lauraceae), originated from Sri 
Lanka (A  et al., 2015; P . E ., 2017). The barks of some other species of this genus, 
Cinnamomum cassia Blume (syn. C. aromaticum Nees) (Chinese cinnamon), C. burmanni 
(Nees & T. Nees) Blume (Indonesian cinnamon), and C. loureiroi Nees (Saigon cinnamon), 
commonly known as “Cassia” barks, are also marketed and sold as cinnamon (L  et 
al., 2008; W  et al., 2013; A  et al., 2015).
Ceylon cinnamon (“true” cinnamon) bark and “Cassia” barks can be distinguished by 
some variations in outer appearance (colour, shape, and thickness) when available in sticks, 
but for the average consumer it is not possible to distinguish between those two types of bark 
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when they are powdered (T  et al., 2006; W  et al., 2010). Regarding their 
chemical composition, the most important diff erence is the coumarin content, which is 
signifi cantly higher in “Cassia” barks than in Ceylon cinnamon bark (M  et al., 1995; 
A  et al., 2015).
Coumarin (benzo-α-pyrone) is a secondary plant metabolite, found in many plants such 
as Melilotus offi  cinalis L. and other species of the genus Melilotus, Dipteryx odorata (Aubl.) 
Willd. (tonka bean), Asperula odorata L., Cinanmomum cassia Blume, Cinnamomum 
burmanni (Nees & T. Nees) Blume, etc. Due to its specifi c smell, which is sweet and fresh, 
reminiscent of freshly-mown hay, synthetic coumarin was widely used as a fl avouring agent 
for food and beverages, until the fi rst toxicological concerns were raised in the 1950s (S  
et al., 2008). Hepatotoxicity and carcinogenicity of coumarin at high doses and during 
prolonged exposure have been observed in animal studies. Experimental animals were also 
found to be more susceptible to the occurrence of toxic liver damage than humans, which is 
explained by the diff erent metabolic pathways of coumarin. However, hepatotoxic metabolites 
may occur in some individuals (with CYP2A6 gene polymorphism, some liver diseases, 
chronic lymphedema), hence coumarin cannot be considered completely safe. More recent 
studies showed that coumarin is not a genotoxic carcinogen, so that a certain limited daily 
intake may be considered acceptable (EFSA, 2004; A  et al., 2010). In that context, 
tolerable daily intake (TDI) of 0.1 mg/kg of coumarin per body weight/day was established 
by the European Food Safety Authority (EFSA, 2004) and the German Federal Institute for 
Risk Assessment (B R, 2006).
Chinese, Indonesian, and Saigon cinnamon barks are cheaper, more widely marketed, 
and more commonly used as a spice than the Ceylon cinnamon bark. In recent years, they 
have been replacing the “true” cinnamon on the markets of Europe, as well as in the USA and 
Canada (S   W , 2004; L  et al., 2008; W  et al., 2013). In 
most cases, the type and origin of cinnamon is not indicated on the label of the spice product 
(W  et al., 2010; B   S , 2012). Considering that coumarin is present 
in much higher concentrations in the “Cassia” barks (Chinese, Indonesian, and Saigon 
cinnamon), high exposure to these products may be unfavourable from a safety point of view.
A number of techniques have been used for the determination of coumarin in cinnamon 
samples, alone or along with other compounds. Less specifi c and/or poorly selective methods 
such as titrimetric, spectrophotometric, or fl uorescent analyses (L  & S , 
2006) are mainly replaced with chromatographic techniques. Suitable method performance 
was observed using thin-layer chromatography (P  et al., 1995), HPLC (S  et al., 
2008; W  et al., 2010; B   S , 2012), GC-MS (M  et al., 1995), 
and, more recently, with LC-MS (W  et al., 2013; A  et al., 2018). 
Nevertheless, HPLC methods are widely used because of their simplicity and reliability.
In this framework, the aim of this study was to determine the coumarin content in 
cinnamon bark samples, as well as in cinnamon-containing dietary supplements available in 
Serbia using a HPLC method.
1. Materials and methods
1.1. Samples
Sixteen commercial samples of cinnamon bark (B1–B16) (Table 1) were purchased from 
supermarkets and health food stores, and two cinnamon-containing dietary supplements (S1 
and S2) (Table 2) were purchased from pharmacies in Serbia.
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Among the samples of cinnamon bark, 12 samples were powdered bark and 4 samples 
were in sticks. Dietary supplements were in the form of tablets.
Three samples of cinnamon bark (B14, B15, and B16), purchased from specialised 
health food stores, originated from Sri Lanka, and they were specifi ed as Ceylon cinnamon 
(“true” cinnamon). On the packaging of other commercial samples of cinnamon bark, 
botanical origin (i.e. Cinnamomum species) was not indicated, with the exception of one 
sample (B2), which was specifi ed as the bark of C. burmanni. The country of origin of most 
samples was Indonesia, except for the sample B8 that came from China (Table 1). Neither 
dietary products contained information on botanical origin of cinnamon bark.
1.2. Sample extraction
Five grams of the bark samples (powder or previously pulverised sticks) were sonicated in 20 
ml of 80% (v/v) MeOH and fi ltered to a 50 ml volumetric fl ask. The procedure was repeated, 
fi ltrates were combined, and the fi nal volume was adjusted to 50 ml.
Ten tablets of each dietary supplement were pulverised with mortar and pestle, adequate 
amounts were weighted (6.7 g for sample S1 and 6.2 g for sample S2) and extracted in the 
same manner as bark samples. Fifty millilitres of obtained fi ltrate was evaporated to dryness 
under reduced pressure (Rotavapor RII, Büchi) and redissolved in 5 ml of 80% (v/v) MeOH. 
Prior to injection, extracts were fi ltered through a 0.45 μm syringe fi lter (Captiva, Agilent 
Technologies).
1.3. HPLC analysis
HPLC analysis was performed on an Agilent 1100 HPLC system with diode–array detection 
under the following conditions: Zorbax Eclipse XDB-C18 analytical column (250 × 4.6 mm; 
particle size 5 μm), fl ow rate 0.8 ml min–1, temperature 25 ºC, injection volume 20 μl. Gradient 
elution was applied with binary mobile phase consisting of solvent A, 0.03% phosphoric 
acid, and solvent B, 10% of A in acetonitrile: initial 30% of B, rising to 50% in 15 min, 15–20 
min rising to 80% of B, and returning to initial conditions till 25 min. The chromatograms 
were recorded at 275 nm.
1.4. Quantifi cation of coumarin
External calibration method was validated in accordance with published guidelines 
(T  et al., 2002; ICH, 2005; FDA, 2018) and applied for the quantifi cation of 
coumarin. Stock standard solution was prepared by dissolving 100 mg of coumarin standard 
(Serva, Germany) in 80% methanol and adjusting the fi nal volume to 100 ml (1.0 mg ml–1). 
Seven dilutions of coumarin with concentrations ranging from 0.005–0.5000 mg ml–1 were 
prepared and analysed by HPLC under the same conditions used for extracts. Standard 
solutions were injected three times and results were used to calculate regression line 
(y=105507x+29.778, r2=0.9997). Linearity was assessed by lack of fi t test (Fcalc=1.87, 
Ftab=2.96, P=0.05). The repeatability of analysis was assessed from ten measurements of the 
same sample (sample B6) (RSD=3.98%). LOD (0.002 mg ml–1) was estimated by visual 
inspection of chromatograms of the standard solution and calculation of signal-to-noise ratio 
(S/N>3). LOQ was determined as the lowest concentration of the standard used for the 
calibration curve (0.005 mg ml–1) as RSD of repeated injections was <20%. Recovery 
experiments were carried out using standard solutions at two concentration levels 
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(0.01 mg ml–1 and 0.05 mg ml–1), resulting in recovery values of 99.8% and 99.6%, 
respectively.
For cinnamon bark samples, the coumarin content obtained from calibration curve in 
mg ml–1 was calculated per g of sample and expressed as mg g–1. For cinnamon-containing 
dietary supplements, the results are expressed in mg of coumarin/tablet and in mg of 
coumarin/g of cinnamon bark. The results are expressed as mean ± standard deviation (SD) 
from three repeated analyses.
2.  Results and discussion
2.1. Coumarin content in commercial samples of cinnamon bark
The coumarin content in the commercially available cinnamon bark samples on the Serbian 
market is reported in Table 1. Coumarin was present in all investigated samples. As expected, 
the lowest content of coumarin was determined in Ceylon cinnamon bark samples that 
originated from Sri Lanka: 0.08 mg g–1 in sample B14, 0.14 mg g–1 in sample B16, and 0.15 
mg g–1 in sample B15. This is in accordance with previous fi ndings on low coumarin content 
in the Ceylon cinnamon bark: in commercial bark samples from the USA it ranged from 
0.007–0.09 mg g–1 (W  et al., 2013) and in those from Germany it was <LOD (limit of 
detection) to 0.19 mg g–1 (M  et al., 1995) and from <LOD to 0.486 mg g–1 (W  
et al., 2010), whereas authentic samples of C. verum barks, originated from plantations in 
South India contained 0.0123–0.143 mg g–1 of coumarin (A  et al., 2018). 
The other 13 currently tested samples contained signifi cantly higher amounts of coumarin 
ranging between 1.38 and 5.80 mg g–1. Coumarin contents in these samples are consistent 
with previous results obtained for commercial samples of Indonesian (2.14–9.30 mg g–1) and 
Saigon cinnamon barks (1.06–6.97 mg g–1) (W  et al., 2013). Similarly to the currently 
analysed samples, the samples of cinnamon bark present on the markets of several EU states 
contained signifi cant amounts of coumarin. Powdered cinnamon barks designated as “Cassia” 
cinnamon from the German market contained 2.88–4.82 mg g–1 of coumarin (S  et al., 
2008). Commercial cinnamon samples available in the Czech Republic contained 2.65–7.02 
mg g–1 (B   S , 2012) and those from Italy up to 4.45 mg g–1 of coumarin 
(L  et al., 2008).
The obtained results indicate that the majority of commercial cinnamon bark samples on 
the Serbian market do not originate from the Ceylon cinnamon but from other species of this 
genus, most probably C. burmanni (Indonesian cinnamon). The situation is similar in other 
countries in Europe, as well as in the USA and India, where samples of “Cassia” barks also 
prevail among the cinnamon samples on the market (L  et al., 2008; W  et al., 
2013; A  et al., 2018).
Considering that coumarin is present in much higher concentrations in the Indonesian, 
Chinese, and Saigon cinnamon barks, a high intake of these products, especially by sensitive 
individuals, can pose a potential health risk.
Since TDI of coumarin established by EFSA is 0.1 mg kg–1 body weight per day (EFSA, 
2004), for person of average body weight (70 kg) daily amount of coumarin should not 
exceed 7 mg. By consuming one teaspoon (5 g) of the majority of the investigated samples 
(B1, B2, B3, B4, B5, B7, B8, B9, B10, and B12) other than Ceylon cinnamon barks (B14, 
B15, and B16), the tolerable daily intake of coumarin would be exceeded. Because of the 
high coumarin content, certain samples should not be administered in quantities of more than 
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1.2 g (sample B1) and 1.6 g (samples B12 and B5) per day (for a person of 70 kg TM). 
According to the recommendation of the German BfR (BfR, 2006), “Cassia” barks should be 
used moderately, and consumers who often use large amounts of cinnamon should opt for a 
Ceylon cinnamon bark because of the signifi cantly smaller amount of coumarin.
Table 1. Coumarin content in cinnamon bark commercial samples











B9 Powder/ Indonesia 2.87±0.02
B10 Powder/Indonesia 1.59±0.05
B11 Sticks/Indonesia 1.39±0.20 
B12 Sticks/Indonesia 4.48±0.18
B13 Sticks/China 1.38±0.20
B14 Sticks/Sri Lanka 0.08±0.02
B15 Powder/Sri Lanka 0.15±0.01
B16 Powder/Sri Lanka 0.14±0.04
2.2. Coumarin content in commercial dietary supplements containing cinnamon bark
Two dietary supplements containing cinnamon bark available in pharmacies in Serbia were 
also analysed for coumarin content. The botanical source of cinnamon bark that was used for 
production was not indicated on the label of the product.
Cinnamon based dietary supplements contained 0.007 mg coumarin/tablet (sample S1) 
and 1.19 mg coumarin/tablet (sample S2) (Table 2). Since the analysed supplements contained 
diff erent quantities of cinnamon bark in one tablet, concentration of coumarin was also 
calculated in mg of coumarin/g of cinnamon bark (Table 2). The obtained results indicate that 
supplement S2 is not manufactured from Ceylon cinnamon bark, but from the bark of some 
other Cinamomum species, i.e. “Cassia” bark, whereas for the supplement S1, the origin of 
cinnamon bark cannot be reliably determined based on the coumarin content.
Table 2. Coumarin content in commercial dietary supplements containing cinnamon bark
Product
No.
Product description (Content in 1 tablet) Coumarin content
mg/tablet
Mean ± SD
mg g–1 of cinnamon bark
S1 100 mg of powdered cinnamon bark 0.007±0.0007 0.07
S2 360 mg of powdered cinnamon bark 1.19±0.01 3.19
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Bearing in mind that a TDI of coumarin is 0.1 mg kg–1, by taking 3 tablets of sample S1, 
which is the recommended daily dose given in the leafl et of the dietary supplement, the 
tolerable daily intake (for a person of average body weight of 70 kg) will not be exceeded. 
However, recommended daily dose for sample S2 is 3–6 tablets, and if sample S2 is taken at 
the maximum daily dose (6 tablets), TDI of coumarin will be exceeded (for a person of body 
weight of 70 kg).
3. Conclusions
The results of the present study revealed that most samples of cinnamon bark on the Serbian 
market had high coumarin contents, indicating that they do not originate from the Ceylon 
cinnamon (Cinnamomum verum) but from other Cinnamomum species. On the other hand, 
HPLC analysis showed low coumarin contents in the samples labelled as Ceylon cinnamon 
that are purchased from specialised healthy food shops. In addition, it is shown that coumarin 
TDI may be exceeded by consuming a number of the studied cinnamon bark samples, as well 
as by taking higher doses of a particular cinnamon-containing dietary supplement. Bearing in 
mind that the large amounts of coumarin may be potentially hepatotoxic, and that the TDI of 
coumarin is established, the consumed amount of certain products should be considered. In 
this regard, the obtained results suggest that the botanical origin of the cinnamon bark should 
be indicated; also that the quality control of cinnamon-based products should comprise 
coumarin quantifi cation and that the content of coumarin should be stated on the product 
label.
*
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